Evidence map›Paper›PMID 24772307›Full record

ArticleMolecular and clinical oncology2014

Hyperthermic intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil in patients at high risk of peritoneal metastasis from colorectal cancer: A preliminary clinical study.

Tomoharu Shimizu, Satoshi Murata, Hiromichi Sonoda, Eiji Mekata, Hiroyuki Ohta, Katsushi Takebayashi, Tohru Miyake, Tohru Tani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. A humanPleura and peritoneum · 2021
    Article
  4. Article
  5. Review
  6. Detection of DT-diaphorase Enzyme with a ParaCEST MRI Contrast Agent.Chemistry (Weinheim an der Bergstrasse, Germany) · 2017
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomoharu ShimizuDepartment of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Satoshi MurataDepartment of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Hiromichi SonodaDepartment of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Eiji MekataDepartment of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Hiroyuki OhtaDepartment of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Katsushi TakebayashiDepartment of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Tohru MiyakeDepartment of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.
Tohru TaniDepartment of Surgery, Shiga University of Medical Science, Otsu, Shiga 520-2192, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although hyperthermic intraperitoneal chemotherapy (HIPEC) has been extensively used to treat patients with peritoneal metastases (PM) from colorectal cancer (CRC), a standard protocol has not yet been established. The aim of this preliminary clinical study was to confirm

Indexed as

5-fluorouraciladjuvantcombinationhyperthermic intraperitoneal chemotherapymitomycin C

Identifiers

PMID24772307
PMCPMC3999119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.